[Skip to Content]

Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom – (Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom, Published online: 2018-12-12; | doi:10.1038/s41433-018-0303-0)

Dec 12
2018

Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom, Published online: 12 December 2018; doi:10.1038/s41433-018-0303-0 Comment on: A British Ophthalmic Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the

  • 12 December 2018

T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study – (T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study, Published online: 2018-12-11; | doi:10.1038/s41433-018-0304-z)

Dec 11
2018

T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study, Published online: 11 December 2018; doi:10.1038/s41433-018-0304-z T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity

  • 11 December 2018

Clinical features and treatment outcomes of patients with tearing after chemotherapy – (Clinical features and treatment outcomes of patients with tearing after chemotherapy, Published online: 2018-12-10; | doi:10.1038/s41433-018-0305-y)

Dec 10
2018

Clinical features and treatment outcomes of patients with tearing after chemotherapy Clinical features and treatment outcomes of patients with tearing after chemotherapy, Published online: 10 December 2018; doi:10.1038/s41433-018-0305-y Clinical features and treatment outcomes of patients with tearing after chemotherapy

  • 10 December 2018

Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma – (Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma, Published online: 2018-12-10; | doi:10.1038/s41433-018-0254-5)

Dec 10
2018

Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma, Published online: 10 December 2018; doi:10.1038/s41433-018-0254-5 Evaluation of episcleral venous fluid wave during gonioscopy assisted transluminal trabeculotomy in patients with advanced glaucoma

  • 10 December 2018

Is post-operative perfluorocarbon liquid tamponade for macula-on giant retinal tear safer than silicone oil? – (Is post-operative perfluorocarbon liquid tamponade for macula-on giant retinal tear safer than silicone oil?, Published online: 2018-12-07; | doi:10.1038/s41433-018-0287-9)

Dec 07
2018

Is post-operative perfluorocarbon liquid tamponade for macula-on giant retinal tear safer than silicone oil? Is post-operative perfluorocarbon liquid tamponade for macula-on giant retinal tear safer than silicone oil?, Published online: 07 December 2018; doi:10.1038/s41433-018-0287-9 Is post-operative perfluorocarbon liquid tamponade for macula-on giant retinal tear safer than silicone oil?

  • 7 December 2018